Ailomics Therapeutics

Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors.

Ailomics Therapeutics is active in the biotechnology, pharmaceutical, therapeutics space based in Asia-Pacific (APAC), founded in 2022.

Within the biotechnology, pharmaceutical, therapeutics space, the company focuses on its core offering rather than a broad product line.

Asia-Pacific (APAC) is where the company is located.

The company is listed at the Angel stage of development.

The company reports a headcount in the c_00011_00050 range.

Sector	Biotechnology, Pharmaceutical, Therapeutics
Headquarters	Asia-Pacific (APAC)
Country	CN
Founded	2022
Employees	c_00011_00050
Stage	angel

Website: www.ailomics.com

Emails and contact routes are reserved for registered members.
Create a free account

Browse related